Escalon Medical Corp. Stock

Equities

ESMC

US2960743050

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 01:51:24 2024-04-17 pm EDT 5-day change 1st Jan Change
0.247 USD +32.80% Intraday chart for Escalon Medical Corp. +32.44% -5.40%
Sales 2022 10.7M Sales 2023 12.18M Capitalization 1.85M
Net income 2022 - Net income 2023 - EV / Sales 2022 0.14 x
Net Debt 2022 611K Net Debt 2023 205 EV / Sales 2023 0.15 x
P/E ratio 2022
-28 x
P/E ratio 2023
8.37 x
Employees 38
Yield 2022 *
-
Yield 2023
-
Free-Float 98.1%
More Fundamentals * Assessed data
Dynamic Chart
Escalon Medical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Escalon Medical Corp. Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
Escalon Medical Corp. Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Escalon Medical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023 CI
Escalon Medical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022 CI
Escalon Medical Corp. Reports Earnings Results for the First Quarter Ended September 30, 2022 CI
Escalon Medical Corp. Reports Earnings Results for the Full Year Ended June 30, 2022 CI
Escalon Medical Corp. Auditor Raises 'Going Concern' Doubt CI
Escalon Medical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022 CI
Escalon Medical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021 CI
Escalon Medical Corp. Reports Earnings Results for the First Quarter Ended September 30, 2021 CI
Escalon Medical Corp. Reports Earnings Results for the Full Year Ended June 30, 2021 CI
Escalon Medical Corp. Auditor Raises 'Going Concern' Doubt CI
Escalon Medical Corp. Reports Earnings Results for the Third Quarter Ended March 31, 2021 CI
Escalon Medical Corp. Reports Earnings Results for the Second Quarter Ended December 31, 2020 CI
More news
1 day+32.80%
1 week+32.44%
Current month-0.40%
1 month+17.62%
3 months+37.22%
6 months-14.09%
Current year-5.40%
More quotes
1 week
0.20
Extreme 0.2
0.25
1 month
0.19
Extreme 0.186
0.25
Current year
0.16
Extreme 0.161
0.27
1 year
0.07
Extreme 0.065
0.39
3 years
0.05
Extreme 0.05
0.44
5 years
0.00
Extreme 0
0.55
10 years
0.00
Extreme 0
1.88
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 00-10-31
Director of Finance/CFO 55 96-12-31
Members of the board TitleAgeSince
Director/Board Member 61 02-12-31
Chief Executive Officer 58 00-10-31
Director/Board Member 48 18-02-12
More insiders
Date Price Change Volume
24-04-17 0.247 +32.80% 1,253

Delayed Quote OTC Markets, April 17, 2024 at 01:51 pm EDT

More quotes
Escalon Medical Corp. operates in the healthcare market, specializing in the development, manufacture, marketing and distribution of medical devices for ophthalmic applications. The Company's A-Scan provides information about the internal structure of the eye by sending a beam of ultrasound along a fixed axis through the eye and displaying the various echoes reflected from the surfaces intersected by the beam. Its B-Scan is primarily a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque. Its UBM is a high-frequency/high-resolution ultrasound device, designed to provide information about the anterior segment of the eye. The Company's pachymeter measures the thickness of the cornea. It distributes two intraocular gas products, C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery. The Company also provides surgical packs and AXIS image management system software.
More about the company